CIPO Patents = 3 (Patent Applications = 1)

EPO Patents = 4 (Patent Applications = 1)

Average Co-Inventor Count = 5.9

ph-index = 5

Forward Citations = 58(Granted Patents)

Location History:

Kyoto, JP (2002 - 2015)
Suita, JP (2014 - 2015)

Company Filing History:

7 out of 318

Taiho Pharmaceutical Company Limited

patents

5 out of 19

Osaka Bioscience Institute

Japan Science and Technology Corporation

Japan Science and Technology Agency

patents

7. 1 out of 68

Oriental Yeast Co., Ltd.

patents

8. 1 out of 40

National Center of Neurology and Psychiatry

patents

9. 3 out of 832,680

Other

patents

where one patent can have more than one assignee

Years Active: 2002-2015

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9181183 - Prostaglandin D synthase inhibitory piperidine compounds (2015-11-10),

2. 9062035 - Piperazine compound capable of inhibiting prostaglandin D synthase (2015-06-23),

3. 8865714 - Piperazine compound capable of inhibiting prostaglandin D synthase (2014-10-21),

4. 8765750 - Piperazine compound having a PGDS inhibitory effect (2014-07-01),

5. 8658390 - Method for detecting muscle degenerative diseases, and method for determining therapeutic efficacy on the diseases (2014-02-25),

6. 8568967 - Method for diagnosis of severity and prediction of recurrence in eosinophilic inflammatory disease (2013-10-29),

7. 7951956 - Benzoimidazole compound capable of inhibiting prostaglandin D synthetase (2011-05-31),

8. 7547532 - Three-dimensional structure of prostaglandin D synthase and utilization thereof (2009-06-16),

9. 7399596 - Method for predicting pregnancy-induced hypertension (2008-07-15),

10. 7314727 - Methods to facilitate diagnosis of normal pressure hydrocephalus (2008-01-01),

11. 7238718 - Method for treating myolytic disease and method for screening antimyolytic agent (2007-07-03),

12. 7202394 - Animal with the mass expression of human gene and test method by using the animal (2007-04-10),

13. 7109044 - Method of detection and disease state management for renal diseases (2006-09-19),

14. 6790635 - Method for restenosis following coronary vessel intervention (2004-09-14),

15. 6605705 - Prostaglandin D synthase-specific monoclonal antibody (2003-08-12),

Title: Innovations of Yoshihiro Urade

Introduction

Yoshihiro Urade is a prominent inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that inhibit prostaglandin D synthase. With a total of 16 patents to his name, Urade's work has had a considerable impact on medical research and drug development.

Latest Patents

Among his latest patents, Urade has developed piperidine compounds that inhibit prostaglandin D synthase. The invention provides a piperidine compound represented by Formula (I), where specific variables are defined in the description. Additionally, he has created a piperazine compound capable of inhibiting prostaglandin D synthase, also represented by Formula (I). These innovations are crucial for advancing therapeutic options in various medical conditions.

Career Highlights

Throughout his career, Yoshihiro Urade has worked with notable organizations such as Taiho Pharmaceutical Company Limited and Osaka Bioscience Institute. His experience in these institutions has allowed him to refine his expertise in pharmaceutical research and development.

Collaborations

Urade has collaborated with esteemed colleagues, including Kosuke Seiki and Hiroshi Oda. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Yoshihiro Urade's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a leading inventor. His work continues to influence the development of new therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.